Commercial laboratories partners have access to Mayo Clinic Laboratories full menu of subspecialty testing, which spans the spectrum of medical specialties.
Including carrier screening, molecular testing, and cytogenetic analysis, Mayo Clinic Laboratories prenatal evaluations provide vital insights for prospective and expecting parents.
Genetic liver disease - Insights
Identifying underlying genetic disorders plays an important role in the treatment and care of patients with liver disease. Appropriate use of screening tests in routine clinical practice can rule out possible causes of liver disease and...
Mosquito-borne disease - Insights
View our comprehensive menu of individually orderable tests and panels for mosquito-borne diseases and our algorithmic approach to testing.
Neurodevelopmental disorders - Insights
Learn more about how chromosomal microarray can be used as a first-tier diagnostic test for those with congenital abnormalities and developmental disabilities.
Confirmatory testing - Insights
Use of mass spectrometry technology in Mayo Clinic Laboratories’ confirmatory drug testing enables accurate identification of parent drugs and metabolites, equipping providers with confidence about their patients’ drug use.
Learn more about how Mayo Clinic Laboratories’ targeted, high-resolution screening panel for stimulant use identifies and confirms the presence of 10 stimulants and phencyclidine (PCP) with a single test.
Chain of custody drug testing - Insights
Chain of custody testing at Mayo Clinic Laboratories is performed on urine, serum, and meconium and adheres to the highest quality standards to provide secure results.
Therapeutic drug monitoring - Insights
Learn more about Mayo Clinic Laboratories’ clinically driven approach to therapeutic drug monitoring.
Hereditary causes of kidney stones - Insights
Learn about our kidney stone panel, which assesses 72 genes associated with inherited conditions that can lead to stone development.